decisionhealth Newsletters, Coder Pink Sheets - 2004 Issue 7 (July)
Fecal Occult Procedures Approved as Waived Test Under CLIA by the FDA
Subscribe or sign in to view the full article.
Article Overview
This article covers fecal occult-blood testing in the GI setting, including CLIA-waived status, Medicare processing guidance, and related coverage and diagnosis considerations. It is relevant to practices, coders, and billing staff who need to understand how federal laboratory rules and Medicare policy affect reporting and payment for these tests.
Why This Topic Matters
Understanding the CLIA-waived status and related Medicare requirements helps GI practices and billing teams confirm whether testing can be performed in-office and how the service is identified for claims processing.
What You Will Learn
- How CLIA-waived status applies to fecal occult-blood testing
- Which federal Medicare and FDA references are cited in connection with the test
- What general billing and coverage considerations are mentioned for screening and diagnostic occult blood services
- Why diagnosis and modifier reporting are part of the article's focus
Who Should Read This
- GI practices
- Medical coders
- Billing staff
- Compliance staff
- Primary care offices
- Medicare billing personnel
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com